Skip to content

Efficacy of continuous thoracic paravertebral block for postherpes neuralgia patients

Efficacy of continuous thoracic paravertebral block for postherpes neuralgia patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052559
Enrollment
Unknown
Registered
2021-10-31
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postherpes neuralgia

Interventions

Group 1:continuous epidural catheterization
Group 2:continuous thoracic paravertebral catheterization

Sponsors

Nanjing Medical University Affiliated Wuxi People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The PHN diagnosis was based on the diagnostic criteria of the International Association for the Study of Pain (IASP); 2. Aged > 18 years; 3. Course of chronic pain > 30 days; 4. Pain distributed in T1-T12; 5. Numeric rating scale (NRS) score > 6.

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of the heart, lung, liver, and kidney; 2. Acute systemic infection or serious immune disorders; 3. Infection of the skin overlying the vertebra of the affected dermatome; 4. Coagulation abnormalities; 5. Allergy to the drugs used in this study; 6. Psychiatric diseases.

Design outcomes

Primary

MeasureTime frame
Numerical Pain Rating Scale;

Countries

China

Contacts

Public ContactZhang Xin

Nanjing Medical University Affiliated Wuxi People’s Hospital

zhisrich@hotmail.com+86 13818832760

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026